Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;12(10):1899-1907.
doi: 10.1111/jdi.13550. Epub 2021 May 4.

Midlife and late-life diabetes and sarcopenia in a general older Japanese population: The Hisayama Study

Affiliations

Midlife and late-life diabetes and sarcopenia in a general older Japanese population: The Hisayama Study

Kimitaka Nakamura et al. J Diabetes Investig. 2021 Oct.

Abstract

Aims/introduction: To investigate the association between midlife or late-life diabetes and the development of sarcopenia in an older Japanese population.

Materials and methods: A total of 824 Japanese residents aged 65 to 84 years without sarcopenia were followed up from 2012 to 2017. Sarcopenia was determined following the Asian Working Group for Sarcopenia definition. The time of diabetes diagnosis was classified as midlife or late-life diabetes by the age at first diagnosis of diabetes (< 65 or ≥ 65 years) based on annual health checkups data over the past 24 years. The duration of diabetes was categorized into three groups of < 10, 10-15, and > 15 years. The odds ratios of incident sarcopenia according to the diabetic status were estimated using a logistic regression analysis.

Results: During follow-up, 47 subjects developed sarcopenia. The multivariable-adjusted odds ratio for incident sarcopenia was significantly greater in subjects with diabetes at baseline than in those without it (odds ratio 2.51, 95% confidence interval 1.26-5.00). Subjects with midlife diabetes had a significantly greater risk of incident sarcopenia, whereas no significant association between late-life diabetes and incident sarcopenia was observed. With a longer duration of diabetes, the risk of incident sarcopenia increased significantly (P for trend = 0.002).

Conclusions: The present study suggests that midlife diabetes and a longer duration of diabetes are significant risk factors for incident sarcopenia in the older population. Preventing diabetes in midlife may reduce the risk of the development of sarcopenia in later life.

Keywords: Diabetes; Prospective cohort study; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

No potential conflicts of interest relevant to this article were reported.

Figures

Figure 1
Figure 1
Flow chart of the study sample selection.
Figure 2
Figure 2
Multivariable‐adjusted odds ratios for the development of sarcopenia by the duration of diabetes. Values on each bar are shown as odds ratios (95% confidence intervals). Odds ratios were adjusted for age, sex, body mass index, education level, hypertension, estimated glomerular filtration rate, dementia, activities of daily living disability, history of cardiovascular disease or cancer, history of fracture, regular exercise habits, current smoking, current drinking, total energy intake, and number of health checkup visits between 1988 and 2012. *P < 0.01 vs. no diabetes.
Figure 3
Figure 3
Multivariable‐adjusted odds ratios for the development of sarcopenia by the age at first diagnosis of diabetes. Values on each bar are shown as odds ratios (95% confidence intervals). Odds ratios were adjusted for age, sex, body mass index, education level, hypertension, estimated glomerular filtration rate, dementia, activities of daily living disability, history of cardiovascular disease or cancer, history of fracture, regular exercise habits, current smoking, current drinking, total energy intake, and number of health checkup visits between 1988 and 2012. *P < 0.01 vs. no diabetes.

References

    1. Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010; 39: 412–423. - PMC - PubMed
    1. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 2014; 15: 95–101. - PubMed
    1. Beaudart C, Zaaria M, Pasleau F, et al. Health outcomes of sarcopenia: a systematic review and meta‐analysis. PLoS One 2017; 12: 1–16. - PMC - PubMed
    1. Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 2015; 16: 247–252. - PubMed
    1. Nakamura K, Yoshida D, Honda T, et al. Prevalence and mortality of sarcopenia in a community‐dwelling older Japanese population: the Hisayama Study. J Epidemiol 2020. 10.2188/jea.JE20190289 - DOI - PMC - PubMed